JP2012511506A5 - - Google Patents

Download PDF

Info

Publication number
JP2012511506A5
JP2012511506A5 JP2011539029A JP2011539029A JP2012511506A5 JP 2012511506 A5 JP2012511506 A5 JP 2012511506A5 JP 2011539029 A JP2011539029 A JP 2011539029A JP 2011539029 A JP2011539029 A JP 2011539029A JP 2012511506 A5 JP2012511506 A5 JP 2012511506A5
Authority
JP
Japan
Prior art keywords
human insulin
desb30
insulin
amino acid
analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011539029A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012511506A (ja
Filing date
Publication date
Priority claimed from PCT/EP2009/053017 external-priority patent/WO2009115469A1/en
Application filed filed Critical
Priority claimed from PCT/EP2009/066335 external-priority patent/WO2010066636A1/en
Publication of JP2012511506A publication Critical patent/JP2012511506A/ja
Publication of JP2012511506A5 publication Critical patent/JP2012511506A5/ja
Withdrawn legal-status Critical Current

Links

JP2011539029A 2008-12-09 2009-12-03 新規インスリンアナログ Withdrawn JP2012511506A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP08171086 2008-12-09
EP08171086.5 2008-12-09
PCT/EP2009/053017 WO2009115469A1 (en) 2008-03-18 2009-03-13 Protease stabilized, acylated insulin analogues
EPPCT/EP2009/053017 2009-03-13
EP09161014.7 2009-05-25
EP09161014 2009-05-25
EP09161232 2009-05-27
EP09161232.5 2009-05-27
PCT/EP2009/066335 WO2010066636A1 (en) 2008-12-09 2009-12-03 Novel insulin analogues

Publications (2)

Publication Number Publication Date
JP2012511506A JP2012511506A (ja) 2012-05-24
JP2012511506A5 true JP2012511506A5 (enExample) 2014-06-19

Family

ID=41651437

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011539029A Withdrawn JP2012511506A (ja) 2008-12-09 2009-12-03 新規インスリンアナログ

Country Status (5)

Country Link
US (1) US20110294729A1 (enExample)
EP (1) EP2376531A1 (enExample)
JP (1) JP2012511506A (enExample)
CN (1) CN102245633A (enExample)
WO (1) WO2010066636A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2910570T (pt) 2008-03-18 2017-01-24 Novo Nordisk As Análogos de insulina acilados, estabilizados contra proteases
JP6013330B2 (ja) 2010-06-23 2016-10-25 ノヴォ ノルディスク アー/エス 追加のジスルフィド結合を含有するヒトインスリン
EP2585484A1 (en) * 2010-06-23 2013-05-01 Novo Nordisk A/S Insulin analogues containing additional disulfide bonds
KR20130036290A (ko) 2010-06-23 2013-04-11 노보 노르디스크 에이/에스 추가 이황화 결합을 함유하는 인슐린 유도체
BR112014025132A2 (pt) 2012-04-11 2017-07-11 Novo Nordisk As formulações de insulina
AU2013325099B2 (en) * 2012-09-25 2018-11-15 The Walter And Eliza Hall Institute Of Medical Research Structure of insulin in complex with n- and c-terminal regions of the insulin receptor alpha-chain
US20140269611A1 (en) * 2013-03-14 2014-09-18 T-Mobile Usa, Inc. Communication Handovers from Networks Using Unlicensed Spectrum to Circuit-Switched Networks
EP3487876A4 (en) * 2016-07-22 2020-02-19 University of Utah Research Foundation INSULIN ANALOGS
PT3554534T (pt) 2016-12-16 2021-11-05 Novo Nordisk As Composições farmacêuticas contendo insulina
BR112021011050A2 (pt) 2018-12-11 2021-08-31 Sanofi Ligante peptídico

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR900701842A (ko) * 1988-07-20 1990-12-04 헨리 브뢰늄 인간 인슐린 동족체와 그를 포함하는 제제
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
AU631868B2 (en) * 1989-04-20 1992-12-10 Mount Sinai School Of Medicine Of The City University Of New York, The Hepatospecific insulin analogues
US5268453A (en) * 1991-08-08 1993-12-07 Scios Inc. Tissue-selective insulin analogs
US6746853B1 (en) * 1999-05-19 2004-06-08 Xencor, Inc. Proteins with insulin-like activity useful in the treatment of diabetes
JP2003518917A (ja) * 1999-05-19 2003-06-17 ゼンコー 糖尿病の処置に有用なインシュリン様活性を有する新規タンパク質
EP2074141B1 (en) * 2006-09-22 2016-08-10 Novo Nordisk A/S Protease resistant insulin analogues
CN101970477B (zh) * 2008-03-14 2014-12-31 诺沃-诺迪斯克有限公司 蛋白酶稳定的胰岛素类似物
PT2910570T (pt) * 2008-03-18 2017-01-24 Novo Nordisk As Análogos de insulina acilados, estabilizados contra proteases

Similar Documents

Publication Publication Date Title
JP2012511506A5 (enExample)
WO2014071405A3 (en) Long-acting single-chain insulin analogues
WO2010014946A3 (en) Halogen-stabilized insulin
JP2013530974A5 (enExample)
EP2717918C0 (en) COMPOSITION FOR THE TREATMENT OF DIABETES COMPRISING A LONG-ACTING INSULIN CONJUGATE AND A LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE
JP2018505146A5 (enExample)
JP2013533227A5 (enExample)
WO2009112583A3 (en) Protease-stabilized insulin analogues
WO2013002580A3 (ko) 폴리에틸렌글라이콜 또는 이의 유도체로 페길화된 엑센딘-4 유사체, 이의 제조방법 및 이를 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학적 조성물
MY167234A (en) Novel glucagon analogues
PH12012501135A1 (en) Insulin analogues with chlorinated amino acids
WO2015128403A3 (en) An a22k, desb27, b29r, des b30, at epsilon position of lysine 22 acylated human insulin analogue
JP2013530702A5 (enExample)
WO2009087082A3 (de) Neue insulinderivate mit extrem verzögertem zeit- / wirkungsprofil
NZ597676A (en) Crystalline anti-hTNFalpha antibodies
WO2009130198A3 (en) Hyperglycosylated human coagulation factor ix
HK1211232A1 (en) Exendin-4 derivatives as dual glp1/gip or trigonal glp1/gip/glucagon agonists
MX336412B (es) Nuevos analogos de glucagon.
JP2013542919A5 (enExample)
CA2729938A1 (en) New insulin analogues of prolonged activity
JP2017500289A5 (enExample)
EP2570873A3 (en) Watch with shapeable strap
WO2010010551A3 (en) Angiopoietin derived peptides
WO2011072288A3 (en) Insulin analogues with chlorinated amino acids
WO2016105545A3 (en) Insulin analogues with enhanced stabilized and reduced mitogenicity